Molecular Diagnostics for Infectious Diseases Market Report – Research, Industry Analysis Reports and Market Demands

Global Molecular Diagnostics for Infectious Diseases Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Molecular Diagnostics for Infectious Diseases Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Respiratory Tract Infections
- 1.3.3 Reproductive Tract Infections
- 1.3.4 Blood-borne Infections (BBIs)
- 1.3.5 Gastrointestinal Infections (GIIs)
- 1.3.6 Other Infections
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Molecular Diagnostics for Infectious Diseases Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Diagnostic Laboratories
1.5 Global Molecular Diagnostics for Infectious Diseases Market Size & Forecast
- 1.5.1 Global Molecular Diagnostics for Infectious Diseases Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Molecular Diagnostics for Infectious Diseases Sales Quantity (2021-2032)
- 1.5.3 Global Molecular Diagnostics for Infectious Diseases Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Molecular Diagnostics for Infectious Diseases by Manufacturer

3.1 Global Molecular Diagnostics for Infectious Diseases Sales Quantity by Manufacturer (2021-2026)
3.2 Global Molecular Diagnostics for Infectious Diseases Revenue by Manufacturer (2021-2026)
3.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Molecular Diagnostics for Infectious Diseases by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Molecular Diagnostics for Infectious Diseases Manufacturer Market Share in 2025
- 3.4.3 Top 6 Molecular Diagnostics for Infectious Diseases Manufacturer Market Share in 2025
3.5 Molecular Diagnostics for Infectious Diseases Market: Overall Company Footprint Analysis
- 3.5.1 Molecular Diagnostics for Infectious Diseases Market: Region Footprint
- 3.5.2 Molecular Diagnostics for Infectious Diseases Market: Company Product Type Footprint
- 3.5.3 Molecular Diagnostics for Infectious Diseases Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Molecular Diagnostics for Infectious Diseases Market Size by Region
- 4.1.1 Global Molecular Diagnostics for Infectious Diseases Sales Quantity by Region (2021-2032)
- 4.1.2 Global Molecular Diagnostics for Infectious Diseases Consumption Value by Region (2021-2032)
- 4.1.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Region (2021-2032)
4.2 North America Molecular Diagnostics for Infectious Diseases Consumption Value (2021-2032)
4.3 Europe Molecular Diagnostics for Infectious Diseases Consumption Value (2021-2032)
4.4 Asia-Pacific Molecular Diagnostics for Infectious Diseases Consumption Value (2021-2032)
4.5 South America Molecular Diagnostics for Infectious Diseases Consumption Value (2021-2032)
4.6 Middle East & Africa Molecular Diagnostics for Infectious Diseases Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
5.2 Global Molecular Diagnostics for Infectious Diseases Consumption Value by Type (2021-2032)
5.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
6.2 Global Molecular Diagnostics for Infectious Diseases Consumption Value by Application (2021-2032)
6.3 Global Molecular Diagnostics for Infectious Diseases Average Price by Application (2021-2032)

7 North America

7.1 North America Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
7.2 North America Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
7.3 North America Molecular Diagnostics for Infectious Diseases Market Size by Country
- 7.3.1 North America Molecular Diagnostics for Infectious Diseases Sales Quantity by Country (2021-2032)
- 7.3.2 North America Molecular Diagnostics for Infectious Diseases Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
8.2 Europe Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
8.3 Europe Molecular Diagnostics for Infectious Diseases Market Size by Country
- 8.3.1 Europe Molecular Diagnostics for Infectious Diseases Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Molecular Diagnostics for Infectious Diseases Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Molecular Diagnostics for Infectious Diseases Market Size by Region
- 9.3.1 Asia-Pacific Molecular Diagnostics for Infectious Diseases Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Molecular Diagnostics for Infectious Diseases Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
10.2 South America Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
10.3 South America Molecular Diagnostics for Infectious Diseases Market Size by Country
- 10.3.1 South America Molecular Diagnostics for Infectious Diseases Sales Quantity by Country (2021-2032)
- 10.3.2 South America Molecular Diagnostics for Infectious Diseases Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Molecular Diagnostics for Infectious Diseases Market Size by Country
- 11.3.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Molecular Diagnostics for Infectious Diseases Market Drivers
12.2 Molecular Diagnostics for Infectious Diseases Market Restraints
12.3 Molecular Diagnostics for Infectious Diseases Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Molecular Diagnostics for Infectious Diseases and Key Manufacturers
13.2 Manufacturing Costs Percentage of Molecular Diagnostics for Infectious Diseases
13.3 Molecular Diagnostics for Infectious Diseases Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Molecular Diagnostics for Infectious Diseases Typical Distributors
14.3 Molecular Diagnostics for Infectious Diseases Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Molecular Diagnostics for Infectious Diseases market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Molecular diagnostics for infectious diseases involves the detection and analysis of microbial genetic material, such as DNA or RNA, to identify and diagnose infections. This advanced diagnostic approach uses techniques like polymerase chain reaction (PCR), nucleic acid amplification, and gene sequencing to detect the specific genetic signatures of pathogens. Molecular diagnostic tests offer high sensitivity and specificity, enabling the rapid and accurate identification of infectious agents, including bacteria, viruses, fungi, and parasites. These tests play a crucial role in disease diagnosis, monitoring treatment efficacy, and guiding appropriate therapeutic interventions, contributing to more targeted and personalized patient care.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market"s expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
This report is a detailed and comprehensive analysis for global Molecular Diagnostics for Infectious Diseases market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Diagnostics for Infectious Diseases market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostics for Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostics for Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostics for Infectious Diseases market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostics for Infectious Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostics for Infectious Diseases market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Illumina, Qiagen, Abbott Laboratories, BioMérieux, Cepheid (Danaher), Thermo Fisher Scientific, Hologic, DiaSorin, Luminex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Molecular Diagnostics for Infectious Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Respiratory Tract Infections
Reproductive Tract Infections
Blood-borne Infections (BBIs)
Gastrointestinal Infections (GIIs)
Other Infections
Market segment by Application
Hospital
Diagnostic Laboratories
Major players covered
Roche Diagnostics
Illumina
Qiagen
Abbott Laboratories
BioMérieux
Cepheid (Danaher)
Thermo Fisher Scientific
Hologic
DiaSorin
Luminex
Hoffmann-La Roche
Biocartis
Nanomix
BioFire Diagnostics
Seegene
QuidelOrtho
ZeptoMetrix
Sansure
BGI Genomics
DaAn Gene
Kehua Bio-engineering
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Molecular Diagnostics for Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Molecular Diagnostics for Infectious Diseases, with price, sales quantity, revenue, and global market share of Molecular Diagnostics for Infectious Diseases from 2021 to 2026.
Chapter 3, the Molecular Diagnostics for Infectious Diseases competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostics for Infectious Diseases breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Molecular Diagnostics for Infectious Diseases market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics for Infectious Diseases.
Chapter 14 and 15, to describe Molecular Diagnostics for Infectious Diseases sales channel, distributors, customers, research findings and conclusion.

Buy now